dndn

Premarket losers: NOVL, NBIX, BDK, TIER, CHINA, BBL, LIFC, ACGY, GRMN,
CPSL, DNDN, AMZN, ZQK, WCI, ACH, BHP, and XTEX. Today will provide us
with some sense on how motivated the sellers are amid signs of
stagflation. For the time being, ...
ùìåí ìëåìí äðééø ðåâò á5 ãåìàø
äàí ùååä ëðéñä ôä? îä ìåç äæîðéí äöôåé ìâáé ðñéåï ðåñó ì÷áìú äàéùåø
äîåï úåãä. __._,_.___. Messages in this topic (1) Reply (via web post)
| Start a new topic. Messages | Files | Photos | Polls | Members |
...
US Reps. Dan Burton, R-Ind., Mike Michaud, D-Maine, and Tim Ryan,
D-Ohio, requested today that the Congress investigate the Food and
Drug Administration's (FDA's) dubious decision to indefinitely delay
the introductio.
Buying Dendreon (DNDN) at $8.3.
Bounce back.
US Reps.
Dan Burton, R-Ind., Mike Michaud, D-Maine, and Tim Ryan, D-Ohio,
requested today that the Congress investigate the Food and Drug
Administration's (FDA's) dubious decision to indefinitely delay the
introductio.
US Reps. Dan Burton, R-Ind., Mike Michaud, D-Maine, and
Tim Ryan, D-Ohio, requested today that the Congress investigate the
Food and Drug Administration's (FDA's) dubious decision to
indefinitely delay the introductio.
Congress asking for info on FDA
approval process citing potential ethics problems in review panel.
DNDN has been complaining that members of the review panel were
biased, on the take from other competitors. DNDN could go above $9
short ...

Buying Dendreon (DNDN) at $8.3.
Also, if you are playing
DNDN for the trade… it currently appears overbought, and hitting the
horizontal resistance. An easing on some of the position should take
place, and buy back on a retreat.
ùìåí ìëåìí äðééø ðåâò á5 ãåìàø äàí
ùååä ëðéñä ôä? îä ìåç äæîðéí äöôåé ìâáé ðñéåï ðåñó ì÷áìú äàéùåø äîåï
úåãä. __._,_.___. Messages in this topic (1) Reply (via web post) |
Start a new topic. Messages | Files | Photos | Polls | Members |
...
Buying Dendreon (DNDN) at $8.3.
Yesterday it was announced that
there are a few people calling for a Congressional investigation into
the FDA decision that DNDN's proposed Provenge to treat prostate
cancer undergo more testing. ...
Dendreon Corporation (DNDN) traded up
24% on Provenge probe request. Najarian says congressional members
think there was some funny business when Provenge wasn't approved.
Freddie Mac (FRE) traded up 7% on no news. ...
Also, if you are
playing DNDN for the trade… it currently appears overbought, and
hitting the horizontal resistance. An easing on some of the position
should take place, and buy back on a retreat.